Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 23 March 2006. doi:10.1136/gut.2005.087668
Gut 2006;55:1398-1402
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2005.087668v1
55/10/1398    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mainie, I
Right arrow Articles by Castell, D O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mainie, I
Right arrow Articles by Castell, D O
Topic Collections
Right arrowRelevant Article

OESOPHAGUS

Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring

I Mainie1, R Tutuian2, S Shay2, M Vela1, X Zhang3, D Sifrim3, D O Castell1

1 Division of Gastroenterology and Hepatology, Medical University South Carolina, Charleston, South Carolina, USA
2 Division of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
3 Centre of Gastroenterological Research, Catholic University of Leuven, Belgium

Correspondence to:
Correspondence to:
Dr I Mainie
Medical University South Carolina, 96 Jonathan Lucas St, 210 Clinical Science Building, PO Box 250327 Charleston. SC 29425, USA; mainie{at}musc.edu

Background and aims: Empiric proton pump inhibitor (PPI) trials have become increasingly popular leading to gastroenterologists frequently evaluating gastro-oesophageal reflux disease (GORD) patients only after they have "failed" PPI therapy. Combined multichannel intraluminal impedance and pH (MII-pH) monitoring has the ability to detect gastro-oesophageal reflux (GOR) episodes independent of their pH and evaluate the relationship between symptoms and all types of GOR. Using this technique, we aimed to characterise the frequency of acid and non-acid reflux (NAR) and their relationship to typical and atypical GOR symptoms in patients on PPI therapy.

Methods: Patients with persistent GORD symptoms referred to three centres underwent 24 hour combined MII-pH monitoring while taking PPIs at least twice daily. Reflux episodes were detected by impedance channels located 3, 5, 7, 9, 15, and 17 cm above the lower oesophageal sphincter (LOS) and classified into acid or non-acid based on pH data from 5 cm above the LOS. A positive symptom index (SI) was declared if at least half of each specific symptom events were preceded by reflux episodes within five minutes.

Results: A total of 168 patients (103 (61%) females and 65 (39%) males; mean age 53 (range 18–85) years) underwent combined MII-pH monitoring while taking PPIs at least twice daily. One hundred and forty four (86%) patients recorded symptoms during the study day and 24 (15%) patients had no symptoms during testing. Sixty nine (48%) symptomatic patients had a positive SI for at least one symptom (16 (11%) with acid reflux and 53 (37%) with NAR) and 75 (52%) had a negative SI. A total of 171 (57%) typical GORD symptoms were recorded, 19 (11%) had a positive SI for acid reflux, 52 (31%) for NAR, and 100 (58%) had a negative SI. One hundred and thirty one (43%) atypical symptoms were recorded, four (3%) had a positive SI for acid reflux, 25 (19%) had a positive SI for NAR, and 102 (78%) had a negative SI.

Conclusion: Combined MII-pH identifies the relation of reflux of all types to persistent symptoms and the importance of NAR in patients taking PPIs.


Abbreviations: MII-pH, multichannel intraluminal impedance and pH; LOS, lower oesophageal sphincter; TLOSR, transient lower oesophageal sphincter relaxation; GOR, gastro-oesophageal reflux; GORD, gastro-oesophageal reflux disease; PPI, proton pump inhibitor; SI, symptom index; SAP, symptom association probability; NAR, non-acid reflux

Keywords: multichannel intraluminal impedance and pH; gastro-oesophageal reflux disease; non-acid reflux


Relevant Article

Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
J P Galmiche
Gut 2006 55: 1379-1381. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
GutHome page
M. Fox and W. Schwizer
Making sense of oesophageal contents
Gut, April 1, 2008; 57(4): 435 - 438.
[Full Text] [PDF]


Home page
Eur Respir JHome page
K. Blondeau, V. Mertens, B. A. Vanaudenaerde, G. M. Verleden, D. E. Van Raemdonck, D. Sifrim, and L. J. Dupont
Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection
Eur. Respir. J., April 1, 2008; 31(4): 707 - 713.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
F Zerbib, A Duriez, S Roman, M Capdepont, and F Mion
Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors
Gut, February 1, 2008; 57(2): 156 - 160.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
L.P.A. McGarvey, L. Polley, and J. MacMahon
Review Series: Chronic cough: Common causes and current guidelines
Chronic Respiratory Disease, November 1, 2007; 4(4): 215 - 223.
[Abstract] [PDF]


Home page
GutHome page
A. J Bredenoord and J. Dent
Proton pump inhibitor-therapy refractory gastro-oesophageal reflux disease patients, who are they?
Gut, April 1, 2007; 56(4): 593 - 594.
[Full Text] [PDF]


Home page
GutHome page
J P Galmiche
Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
Gut, October 1, 2006; 55(10): 1379 - 1381.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology